T 0639/19 (Ulipristal acetate contraception/HRA) of 28.08.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T063919.20200828
- Date of decision
- 28 August 2020
- Case number
- T 0639/19
- Online on
- 1 October 2020
- Petition for review of
- -
- Application number
- 10717084.7
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- METHOD FOR ON-DEMAND CONTRACEPTION
- Applicant name
- Laboratoire HRA Pharma
The United States of America, as represented by
The Secretary, Department of Health and Human
Services - Opponent name
- Teva Pharmaceutical Industries Ltd.
Helm AG
Stada-Arzneimittel Aktiengesellschaft
HEXAL PHARMA AG
Generics (U.K.) Limited
EGIS Gyógyszergyár Zártkörüen Müködö
Részvénytársaság
Mutlu, Aydin - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c) (2007)European Patent Convention Art 123(2) (2007)European Patent Convention R 103 (2014)
- Keywords
- Amendments - added subject-matter (yes)
Amendments - all requests
Reimbursement of appeal fee - (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed.